[1]
Zara, S. et al. 2015. Zoledronate treatment at subtoxic doses delays human primary osteoblasts differentiation. Italian Journal of Anatomy and Embryology. 120, 1 (Sep. 2015), 132. DOI:https://doi.org/10.36253/ijae-4086.